- Huber B, Schellenbacher C, Shafti-Keramat S, Jindra C, Christensen N, Kirnbauer R. Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV). PLoS One. 2017 Jan 5; PMID: 28056100
- Melinda Ahmels, Filipe C. Mariz, Ilona Braspenning-Wesch, Sonja Stephan, Bettina Huber, Gabriele Schmidt, Rui Cao, Martin Müller, Reinhard Kirnbauer, Frank Rösl, Daniel Hasche. Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development. Front Immunol 2022 Oct 3;13:1010790. PMID: 36263027
- Christina Schellenbacher, Kihyuck Kwak, Dieter Fink, Saeed Shafti-Keramat, Bettina Huber, Christoph Jindra, Helena Faust, Joakim Dillner, Richard B.S. Roden, Reinhard Kirnbauer. Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses. J Invest Dermatol Jun 10. (2013) PMID: 23752042
- Christina Schellenbacher, Richard Roden, Reinhard Kirnbauer. Chimeric L1-L2 Virus-like Particles As Potential Broad-Spectrum Human Papillomavirus Vaccines. J Virol 83(819):10085-10095 (2009) PMID: 19640991
- Kirnbauer R, Taub J, Greenstone H, Roden R, Dürst M, Gissmann L, Lowy DR, Schiller JT: Efficient Self-Assembly of Human Papillomavirus Type 16 L1 and L1 plus L2 into Virus-Like Particles. J Virol 67(12): 6929-6936 (1993) PMID: 8230414
- Kirnbauer R, Booy F, Cheng N, Lowy DR, Schiller JT: Papillomavirus L1 major capsid proteins self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA 89: 12180-12184 (1992) PMID: 1334560
